Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaletra Monotherapy Simplification in HIV
NCT00159224Phase 4Completed
- Sponsor
- Fundación Huésped
- Start
- Apr 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, open-label trial of lopinavir + ritonavir in human immunodeficiency virus type 1 infection (HIV-1) (2 arms), sponsored by Fundación Huésped. Primary endpoint: Proportion of patients remaining undetectable below 50 copies/mL at 48 weeks. Started Apr 2005; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00159224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159224.